Local view for "http://purl.org/linkedpolitics/eu/plenary/2007-12-11-Speech-2-162"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2007-12-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"cs"^^xsd:language2
lpv:document identification number	"en.20071211.32.2-162"2
lpv:hasSubsequent	lp_eu:2007-12-11-Speech-2-1632
lpv:speaker	lp:Zuzana Roithová2
lpv:spokenAs	substitute; INTA (2007-01-31--2009-07-13)3 vice-chair; IMCO (2007-01-31--2009-07-13)3 member; Delegation to the ACP-EU Joint Parliamentary Assembly (2004-09-15--2009-07-13)3 substitute; FEMM (2007-01-31--2009-07-13)3 member; EPP-ED (2004-07-20--2009-07-13)3 unknown; Křesťanská a demokratická unie - Československá strana lidová (2004-07-20--2009-07-13)3
lpv:translated text	"Mr President, I am one of the critics of the lack of cooperation between large corporations and universities and I also object to the low level of resources available for research within the EU, due to the fact that, compared with the US, only one third of funding here comes from the private sector. Today at last we are sending very good news from Strasbourg to the European research industry by adopting a seven-year plan for innovative medicine at the cost of EUR 2 billion. The format of this undertaking is innovative in itself as it represents a partnership between the private and public sectors. This can double the available resources and also helps to unify research targets. I believe it will give a fresh impulse to knowledge management, education and vocational training. I am convinced that we can reverse the trend of falling efficiency in the European pharmaceutical industry and achieve a more easily accessible high-quality treatment, especially of cancer and Alzheimer’s disease. I would like to thank the rapporteur for getting the report to its successful second reading."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph